

No results matched your search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
UNH | NYSE | USD | Real-time | |
UNH | Mexico | MXN | Delayed | |
UNH | TradeGate | EUR | Delayed | |
UNH | Frankfurt | EUR | Delayed | |
UNH | Vienna | EUR | Delayed |
UnitedHealth (NYSE:UNH) declares $1.25/share quarterly dividend, in line with previous.Forward yield 1.52%Payable March 23; for shareholders of record March 15; ex-div March 12.See...
The provider of health care coverage, software, and data consulting firm services says Witty will succeed David S. Wichmann, who is retiring.
UnitedHealth Group (NYSE:UNH) has named Andrew Witty as the new chief executive officer succeeding the current CEO David S.
UNH is down 7.3% for the YTD. The Wall Street consensus outlook is for substantial price appreciation.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
---|---|---|---|---|---|
Moving Averages | Buy | Buy | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy | BUY | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy | Buy | Strong Buy |
Filter Table By:
Pattern | Timeframe | Reliability | Candles Ago | Candle Time | |
---|---|---|---|---|---|
Emerging Patterns | |||||
Three Outside Up | 1W | Current | |||
Completed Patterns | |||||
Bullish Engulfing | 1W | 1 | Feb 21, 2021 | ||
Doji Star Bearish | 15 | 5 | Mar 05, 2021 20:30 | ||
Doji Star Bearish | 1M | 6 | Sep 20 |
Exchange | Last | Bid | Ask | Volume | Change % | Currency | Time | ||
---|---|---|---|---|---|---|---|---|---|
NYSE | 347.10 | 347.00 | 349.50 | 4,563,095 | +3.98% | USD | 05/03 | ||
Mexico | 7,377.00 | 0.00 | 0.00 | 916 | +5.89% | MXN | 05/03 | ||
TradeGate | 290.90 | 290.60 | 291.70 | 929 | +3.45% | EUR | 05/03 | ||
Frankfurt | 288.00 | 0.00 | 0.00 | 121 | +2.38% | EUR | 05/03 | ||
Vienna | 272.800 | 0.000 | 0.000 | 0 | -0.60% | EUR | 21/12 |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
---|---|---|---|---|---|---|---|---|---|
FBN Holdings | 7.10 | 7.10 | 6.85 | +0.05 | +0.71% | 26.50M | 05/03 | ||
MTN Nigeria | 160.20 | 160.20 | 160.20 | -9.80 | -5.76% | 643.20K | 05/03 | ||
Guaranty Trust Bank | 31.20 | 31.05 | 30.90 | -0.50 | -1.59% | 20.83M | 05/03 | ||
Zenith Bank | 25.30 | 25.40 | 24.95 | 0.00 | 0.00% | 46.85M | 05/03 | ||
UBA | 7.95 | 7.95 | 7.85 | 0.00 | 0.00% | 23.30M | 05/03 | ||
Access Bank | 7.90 | 7.85 | 7.70 | +0.10 | +1.28% | 10.47M | 05/03 | ||
Dangote Sugar | 16.90 | 16.90 | 16.40 | +0.40 | +2.42% | 1.98M | 05/03 | ||
Lafarge Africa | 22.20 | 22.20 | 21.80 | +2.00 | +9.90% | 1.65M | 05/03 | ||
STANBIC IBTC Bank | 44.00 | 44.00 | 44.00 | +4.00 | +10.00% | 82.37K | 05/03 | ||
Oando Plc | 2.65 | 3.00 | 2.65 | -0.25 | -8.62% | 4.05M | 05/03 |
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum. UnitedHealthcare provides healthcare benefits to an array of customers and markets, and includes UnitedHealthcare Employer & Individual, UnitedHealthcare Medicare & Retirement, UnitedHealthcare Community & State, and UnitedHealthcare Global businesses. Optum is a health services business serving the healthcare marketplace, including payers, care providers, employers, governments, life sciences companies and consumers, through its OptumHealth, OptumInsight and OptumRx businesses. OptumInsight provides services, technology and healthcare solutions to participants in the healthcare industry. OptumRx provides retail network contracting, purchasing and clinical solutions.
Read MoreAre you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review